AI Article Synopsis
- Recent approvals of PET radiotracers targeting beta-amyloid plaques highlight their role in Alzheimer's disease diagnosis.
- The German Society of Nuclear Medicine has created a guideline outlining proper procedures for Aβ plaque imaging, covering everything from patient prep to data analysis.
- This guideline aims to enhance quality assurance in nuclear imaging practices across Germany.
Article Abstract
Recently, a number of positron emission tomography (PET) radiotracers have been approved for clinical use. These tracers target cerebral beta-amyloid (Aβ) plaques, a hallmark of Alzheimer's disease. Increasing use of this method implies the need for respective standards. This German Society of Nuclear Medicine guideline describes adequate procedures for Aβ plaque PET imaging. It not only discusses the tracers used for that purpose, but also lists measures for correct patient preparation, image data generation, processing, analysis and interpretation. With that, this "S1" category (according to the German Association of the Scientific Medical Societies standard) guideline aims at contributing to quality assurance of nuclear imaging in Germany.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3413/Nukmed-0816-16-04 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!